IFC & Insurance Marketing’s Boston Scientific BSX Stock Holding History

IFC & Insurance Marketing’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-115	Closed	-$11K	–	144
2025 Q4	$11K	Buy	+115	New	+$11.3K	0.01%	373

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IFC & Insurance Marketing's BSX Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 115 shares — an estimated $11K sold.

IFC & Insurance Marketing first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $11K in Q4 2025. 1,678 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

IFC & Insurance Marketing reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 115 Boston Scientific shares in Q1 2026, an estimated $11K.
IFC & Insurance Marketing first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's Boston Scientific position peaked at $11K in Q4 2025.
1,678 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.